11-36503205-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004620.4(TRAF6):​c.-22-1668T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.781 in 152,110 control chromosomes in the GnomAD database, including 47,239 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.78 ( 47239 hom., cov: 32)

Consequence

TRAF6
NM_004620.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.220

Publications

18 publications found
Variant links:
Genes affected
TRAF6 (HGNC:12036): (TNF receptor associated factor 6) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins are associated with, and mediate signal transduction from, members of the TNF receptor superfamily. This protein has an amino terminal RING domain which is followed by four zinc-finger motifs, a central coiled-coil region and a highly conserved carboxyl terminal domain, known as the TRAF-C domain and mediates signaling from members of the TNF receptor superfamily as well as the Toll/IL-1 family. Signals from receptors such as CD40, TNFSF11/RANCE and IL-1 have been shown to be mediated by this protein. This protein also interacts with various protein kinases including IRAK1/IRAK, SRC and PKCzeta, which provides a link between distinct signaling pathways. This protein functions as a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. The interaction of this protein with UBE2N/UBC13, and UBE2V1/UEV1A, which are ubiquitin conjugating enzymes catalyzing the formation of polyubiquitin chains, has been found to be required for IKK activation by this protein. This protein also interacts with the transforming growth factor (TGF) beta receptor complex and is required for Smad-independent activation of the JNK and p38 kinases. The protein encoded by this gene is a key molecule in antiviral innate and antigen-specific immune responses. [provided by RefSeq, Nov 2021]
TRAF6 Gene-Disease associations (from GenCC):
  • autosomal dominant hypohidrotic ectodermal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.851 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
NM_004620.4
MANE Select
c.-22-1668T>C
intron
N/ANP_004611.1Q9Y4K3
TRAF6
NM_145803.3
c.-115-1394T>C
intron
N/ANP_665802.1Q9Y4K3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF6
ENST00000526995.6
TSL:1 MANE Select
c.-22-1668T>C
intron
N/AENSP00000433623.1Q9Y4K3
TRAF6
ENST00000348124.5
TSL:1
c.-115-1394T>C
intron
N/AENSP00000337853.5Q9Y4K3
TRAF6
ENST00000876418.1
c.-22-1668T>C
intron
N/AENSP00000546477.1

Frequencies

GnomAD3 genomes
AF:
0.782
AC:
118798
AN:
151992
Hom.:
47227
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.622
Gnomad AMI
AF:
0.926
Gnomad AMR
AF:
0.863
Gnomad ASJ
AF:
0.811
Gnomad EAS
AF:
0.872
Gnomad SAS
AF:
0.780
Gnomad FIN
AF:
0.825
Gnomad MID
AF:
0.826
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.793
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.781
AC:
118856
AN:
152110
Hom.:
47239
Cov.:
32
AF XY:
0.784
AC XY:
58315
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.622
AC:
25775
AN:
41456
American (AMR)
AF:
0.863
AC:
13203
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.811
AC:
2814
AN:
3470
East Asian (EAS)
AF:
0.872
AC:
4516
AN:
5178
South Asian (SAS)
AF:
0.780
AC:
3758
AN:
4818
European-Finnish (FIN)
AF:
0.825
AC:
8717
AN:
10568
Middle Eastern (MID)
AF:
0.823
AC:
242
AN:
294
European-Non Finnish (NFE)
AF:
0.843
AC:
57307
AN:
68004
Other (OTH)
AF:
0.794
AC:
1681
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1286
2572
3857
5143
6429
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.819
Hom.:
115047
Bravo
AF:
0.778
Asia WGS
AF:
0.814
AC:
2831
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.9
DANN
Benign
0.69
PhyloP100
-0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030437; hg19: chr11-36524755; API